Aldeyra Therapeutics Inc

NASDAQ:ALDX

3.93

-0.01 (-0.25%)

6:09:29 PM EDT: $4.10 +0.17 (+4.33%)

Market Cap (Intraday)	233.51M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.5 Million
Adjusted EPS	-$0.12

See more estimates

10-Day MA	$3.96
50-Day MA	$3.64
200-Day MA	$4.45

See more pivots

Aldeyra Therapeutics Inc Stock, NASDAQ:ALDX

131 Hartwell Avenue, Suite 320, Lexington, Massachusetts 02421

United States of America

Phone: +1.781.761.4904

Number of Employees: 10

http://www.aldeyra.com

Description

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.